Clinical trials
Brain Diseases trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Terminated | 12 |
| Recruiting | 4 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 4 |
| Charite University, Berlin, Germany | 4 |
| University of Rostock | 4 |
| AstraZeneca | 3 |
| TauRx Therapeutics Ltd | 3 |
| Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | 3 |
| Aesculap AG | 1 |
| Affiris AG | 1 |
| Alkahest, Inc. | 1 |
| Avraham Pharmaceuticals Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Diseases | 49 |
| Central Nervous System Diseases | 29 |
| Nervous System Diseases | 25 |
| Neurodegenerative Diseases | 19 |
| Dementia | 15 |
| Alzheimer Disease | 12 |
| Mental Disorders | 11 |
| Cerebrovascular Disorders | 10 |
| Movement Disorders | 9 |
| Stroke | 9 |
Trials
Showing 51 to 49 of 49. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.